Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Certification Training And Oversight topic
No spam. Unsubscribe anytime.
Task force debates certification, scope of practice and grievance processes for potential psychedelic therapies
Summary
Members debated whether the task force should be prescriptive about clinical practice, whether the Controlled Substances Advisory Committee should lead regulation, and proposed a state certification or registry for unlicensed facilitators and stronger grievance notice for patients.
The task force spent extended time discussing how Alaska should regulate clinical practice, training and oversight if psychedelic medicines gain FDA approval.
Doctor Lawrence urged caution about recommending a new clinical working group, saying the task force's statutory charge in HB 228 presumes any state-level action would follow FDA approval. "The scope of this task force is set in the bill in HB 228, and it presumes that if and when something is approved by the FDA," Anna, the staff convenor, told members while framing the group’s role.
Several clinicians argued against overly prescriptive requirements before FDA and standard-of-care guidance are available. "I would advocate against it being too overly prescriptive in this space," Doctor Lindquist said, noting that future evidence could change clinical recommendations. Doctor Kozub (Sarah Kozub) and others said that requiring mandatory collaboration with primary-care clinicians could add cost and reduce access; Kozub also proposed a non-licensed facilitator pathway as one option to increase access while maintaining safety.
Members discussed existing institutions that could perform regulatory functions. Doctor Colescott recommended relying on the statutorily created Controlled Substances Advisory Committee for substance-specific regulatory review rather than creating a new clinical working group; several members supported referencing that committee in the draft recommendations.
On credentialing, the group debated whether to recommend a state-issued certification, an endorsement for already licensed clinicians, or a hybrid model. "In my world, certification or licensure would mean issued by the state," Glenn Saviors said, noting the enforcement advantage of a state credential. Others recommended a registry or endorsement for licensed clinicians and a separate certification path for unlicensed facilitators, with training and scope tied to the care setting.
Several members emphasized guardrails for consent, touch and grievance procedures. Doctor DeMolina described preparation sessions with explicit consent for touch and integration work after medicine sessions and said grievance procedures and notice of patient rights should be visible at clinic intake. Doctor Lindquist cited an existing statutory grievance standard for involuntary psychiatric patients as an example of required notice of rights and recordkeeping.
The panel briefly discussed special populations and federal systems: a member representing military interests noted that Department of Veterans Affairs (VA) policy and TRICARE coverage will shape veterans' access to any future services and that active-duty readiness rules could affect service members.
No final policy decisions were adopted; members agreed they will continue to refine draft recommendations and may include multiple recommendation variants for a later vote after public comment.
